跳至主要内容
临床试验/DRKS00011393
DRKS00011393已完成未知

HIPPOlino - interdisciplinary skin cancer prevention training for immunocompressed children and adolescents - HIPPOlino

Deutsche Krebshilfe e.V.0 个研究点目标入组 127 人开始时间: 2017年1月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
127

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
5 Years 至 22 Years(—)
性别
All

入选标准

  • Organ transplanted children and adolescents aged between 5 and 22 years
  • Type I-III to Fitzpatrick
  • Immunosuppression at the time of inclusion in the study, including complete information on the type, amount and duration of immunosuppression
  • Written consent of the young people and their parents to participate in the study
  • Daily access possibilities of the young people or the parents on a mobile phone for sending SMS
  • Transfer of the telephone number and the place of residence to the German Weather Service
  • Known living-place in the intervention period for sending SMS
  • Signed release from medical confidentiality

排除标准

  • Organ transplant recipients > 22 years
  • No longer required immunosuppression during the study period (e.g., transplant failure)
  • Multi-week stay abroad during the intervening period of access to a mobile phone
  • Skin types IV-VI of Fitzpatrick (extremely low baseline skin cancer risk)

研究者

发起方
Deutsche Krebshilfe e.V.

相似试验